FLT3 and acute myeloid leukemia: In addition when we used the FLT3 inhibitor AC220 in combination with ibrutinib there was no additive effect on AML survival, thus supporting the hypothesis that these two inhibitors are working on the same survival pathway/s in FLT3-ITD AML.